Prerecorded Webinar: Managing Benign Prostatic Hyperplasia: Interdisciplinary Strategies for Improved Outcomes Webinar
Disease State Management/Drug Therapy CE for Pharmacists
Pre-Recorded
Are you a Pharmacy Tech? Check out the Pharmacy Tech version of this course.
Want another way to take this test? Check out the written version of this course.
Course Summary
Within the realm of men’s health conditions, benign prostatic hyperplasia (BPH) is a disorder with major public health consequences. Benign prostatic hyperplasia is a histological diagnosis and refers to a benign growth of prostate tissue. It is a common cause of lower urinary tract symptoms (LUTS), which often progress in prevalence and severity as men age. Patients with BPH require a patient-centered, holistic approach to care that involves improving symptoms and quality of life, preventing disease progression, and minimizing medication side effects. All healthcare providers can play a crucial role in identifying patients who require BPH treatment, recommending referrals, and assisting the care team with BPH medication management. Further, pharmacists can provide crucial counseling on the appropriate use of BPH medications and help patients to mitigate side effects and avoid harmful drug interactions.
Describe the etiology of benign prostatic hyperplasia (BPH)
Compare and contrast treatment strategies for BPH
Recall indications, contraindications, side effect profiles, and monitoring parameters for pharmacologic therapies
Identify the roles of healthcare team members in the management of BPH
Course Syllabus
I. Introduction
II. Overview of Benign Prostatic Hyperplasia
III. Epidemiology
IV. Pathophysiology
V. Etiology
VI. Diagnosis and Evaluation
A. Differential Diagnosis
B. Medications that Exacerbate BPH
VII. Management of BPH
Watchful Waiting
VIII. Pharmacologic Treatment
A. Guideline Summary
B. Alpha-1 Adrenergic Antagonists
C. 5-alpha Reductase Inhibitors
D. Muscarinic Receptor Antagonists
E. Phosphodiesterase-5 Inhibitor (PDE-5)
F. Mirabegron
G. Combination Therapy
H. Nutraceuticals
I. Surgical Interventions and Emerging Therapies
IX. Interprofessional Considerations
X. Summary
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The following individuals were involved in developing this activity: L. Austin Fredrickson, MD, FACP, Liz Fredrickson, PharmD, BCPS, Kristina (Tia) Neu, RN, and Pamela Sardo, PharmD, BS. None of the individuals involved in developing this activity has a conflict of interest or financial relationships related to the subject matter. There are no financial relationships or commercial or financial support relevant to this activity to report or disclose by RxCe.com or any of the individuals involved in the development of this activity.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Computer Hardware/Software Requirements
Please ensure the device you plan to use meets these requirements and specifications:
- Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
- For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.
- Target Audience: Pharmacist
- Secondary Audiences: This educational activity is also for other healthcare professionals, such as nurses, physicians, or others who may be part of a healthcare team and may be interested in this educational topic. A healthcare team approach to patient care may be discussed in this activity, as applicable. No state board or professional organization has evaluated this activity to determine whether it meets the continuing education requirements of nurses, physicians, or other professions not listed under the “Target Audience” described above. Always verify with individual employers or supervisors whether they will accept this educational activity upon completion.
- Contact Hours: 1.0 (0.1 CEUs)
- Activity Release Date: 8/12/2025
- Activity Expiration Date: 8/12/2028
- Activity Type: Knowledge
- UAN: 0669-0000-25-093-H01-P
- Topic: Disease State Management/Drug Therapy
- CeBroker Number: 20-1321615
Faculty:
Preview the Materials:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.